Overexpression of KLF5 inhibits puromycin‑induced apoptosis of podocytes

Li,Yang; Sui,Xiaoni; Hu,Xueqing; Hu,Zhao

doi:10.3892/mmr.2018.9366

Overexpression of KLF5 inhibits puromycin‑induced apoptosis of podocytes

Authors:
- Yang Li
- Xiaoni Sui
- Xueqing Hu
- Zhao Hu
View Affiliations

Affiliations: Department of Nephrology, Qilu Hospital of Shandong University, Jinan, Shandong 250012, P.R. China, Department of Nephrology, Qingdao Municipal Hospital, Qingdao, Shandong 266011, P.R. China
Published online on: August 9, 2018 https://doi.org/10.3892/mmr.2018.9366
Pages: 3843-3849
Copyright: © Li et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Diabetic nephropathy (DN) is one of the most common microvascular complications associated with diabetes mellitus (DM); the incidence has been predicted to reach 7.7% by 2030 on a global scale. Krüppel‑like factor 5 (KLF5) is involved in numerous important biological processes; however, the potential effects of KLF5 on podocytes in patients with diabetic nephrotic (DN) have not yet been investigated. In the present study, synaptopodin expression in podocytes was investigated using an immunofluorescence assay. Following this, the proliferation of podocytes was investigated using an MTT assay. In addition, KLF5 was overexpressed in podocytes, and cell cycle arrest and apoptosis was subsequently investigated using flow cytometry. Western blotting and reverse transcription‑quantitative polymerase chain reaction assays were performed to detect the expression levels of genes involved in the cell cycle and apoptosis, and the extracellular signal‑regulated protein kinase (ERK)/p38 mitogen‑activated protein (MAP) kinase pathway. The results demonstrated that treatment with puromycin aminonucleoside (PAN) suppressed the proliferation of podocytes in a dose‑ and time‑dependent manner, and overexpression of KLF5 induced cell cycle arrest of podocytes regulated by PAN. Furthermore, overexpression of KLF5 was revealed to have inhibited PAN‑induced apoptosis of podocytes, and that overexpression of KLF5 suppressed the ERK/p38 MAP kinase pathway in podocytes induced by PAN. Therefore, the results of the present study suggested that KLF5 may represent a potential therapeutic target for treatment of patients with DN.

View Figures

View References

1	Bikbova G, Oshitari T, Tawada A and Yamamoto S: Corneal changes in diabetes mellitus. Curr Diabetes Rev. 8:294–302. 2012. View Article : Google Scholar : PubMed/NCBI
2	Bril V: Neuromuscular complications of diabetes mellitus. Continuum (Minneap Minn) 20 (3 Neurology of Systemic Disease). 1–544. 2014.
3	Nentwich MM and Ulbig MW: Diabetic retinopathy-ocular complications of diabetes mellitus. World J Diabetes. 6:489–499. 2015. View Article : Google Scholar : PubMed/NCBI
4	Kaul K, Tarr JM, Ahmad SI, Kohner EM and Chibber R: Introduction to diabetes mellitus. Adv Exp Med Biol. 771:1–11. 2012.PubMed/NCBI
5	Brinks R and Rathmann W: Response to Monesi etal Prevalence, incidence and mortality of diagnosed diabetes: Evidence from an Italian population-based study. Diabet Med. 29:1085–1086; author reply 1085. 2012. View Article : Google Scholar : PubMed/NCBI
6	Farag YM and Gaballa MR: Diabesity: An overview of a rising epidemic. Nephrol Dial Transplant. 26:28–35. 2011. View Article : Google Scholar : PubMed/NCBI
7	Chao CT, Huang JW, Chiang CK, Chen YC, Fang CC, Hu FC, Chang CC and Yen CJ: Diabetes mellitus, superoxide dismutase and peroxisome proliferator activated receptor gamma polymorphisms modify the outcome of end-stage renal disease patients of Han Chinese origin. Nephrology (Carlton). 23:117–125. 2018. View Article : Google Scholar : PubMed/NCBI
8	Tagawa A, Yasuda M, Kume S, Yamahara K, Nakazawa J, Chin-Kanasaki M, Araki H, Araki S, Koya D, Asanuma K, et al: Impaired podocyte autophagy exacerbates proteinuria in diabetic nephropathy. Diabetes. 65:755–767. 2016. View Article : Google Scholar : PubMed/NCBI
9	Yasuda-Yamahara M, Kume S, Tagawa A, Maegawa H and Uzu T: Emerging role of podocyte autophagy in the progression of diabetic nephropathy. Autophagy. 11:2385–2386. 2015. View Article : Google Scholar : PubMed/NCBI
10	Kamiyama M, Urushihara M, Morikawa T, Konishi Y, Imanishi M, Nishiyama A and Kobori H: Oxidative stress/angiotensinogen/renin-angiotensin system axis in patients with diabetic nephropathy. Int J Mol Sci. 14:23045–23062. 2013. View Article : Google Scholar : PubMed/NCBI
11	Weening JJ and Rennke HG: Glomerular permeability and polyanion in adriamycin nephrosis in the rat. Kidney Int. 24:152–159. 1983. View Article : Google Scholar : PubMed/NCBI
12	Amann K, Nichols C, Tornig J, Schwarz U, Zeier M, Mall G and Ritz E: Effect of ramipril, nifedipine, and moxonidine on glomerular morphology and podocyte structure in experimental renal failure. Nephrol Dial Transplant. 11:1003–1011. 1996. View Article : Google Scholar : PubMed/NCBI
13	Mifsud SA, Allen TJ, Bertram JF, Hulthen UL, Kelly DJ, Cooper ME, Wilkinson-Berka JL and Gilbert RE: Podocyte foot process broadening in experimental diabetic nephropathy: Amelioration with renin-angiotensin blockade. Diabetologia. 44:878–882. 2001. View Article : Google Scholar : PubMed/NCBI
14	Kim D, Lim S, Park M, Choi J, Kim J, Han H, Yoon K, Kim K, Lim J and Park S: Ubiquitination-dependent CARM1 degradation facilitates Notch1-mediated podocyte apoptosis in diabetic nephropathy. Cell Signal. 26:1774–1782. 2014. View Article : Google Scholar : PubMed/NCBI
15	Courboulin A, Tremblay VL, Barrier M, Meloche J, Jacob MH, Chapolard M, Bisserier M, Paulin R, Lambert C, Provencher S and Bonnet S: Krüppel-like Factor 5 contributes to pulmonary artery smooth muscle proliferation and resistance to apoptosis in human pulmonary arterial hypertension. Respir Res. 12:1282011. View Article : Google Scholar : PubMed/NCBI
16	Tetreault MP, Yang Y and Katz JP: Krüppel-like factors in cancer. Nat Rev Cancer. 13:701–713. 2013. View Article : Google Scholar : PubMed/NCBI
17	Courboulin A, Tremblay VL, Barrier M, Meloche J, Jacob MH, Chapolard M, Bisserier M, Paulin R, Lambert C, Provencher S and Bonnet S: Krüppel-like factor 5 contributes to pulmonary artery smooth muscle proliferation and resistance to apoptosis in human pulmonary arterial hypertension. Respir Res. 12:1282011. View Article : Google Scholar : PubMed/NCBI
18	Limame R, Op de Beeck K, Lardon F, De Wever O and Pauwels P: Krüppel-like factors in cancer progression: Three fingers on the steering wheel. Oncotarget. 5:29–48. 2014. View Article : Google Scholar : PubMed/NCBI
19	Yin KJ, Hamblin M, Fan Y, Zhang J and Chen YE: Krüppel-like factors in the central nervous system: Novel mediators in stroke. Metab Brain Dis. 30:401–410. 2015. View Article : Google Scholar : PubMed/NCBI
20	Chen C, Zhou Z, Guo P and Dong JT: Proteasomal degradation of the KLF5 transcription factor through a ubiquitin-independent pathway. FEBS Lett. 581:1124–1130. 2007. View Article : Google Scholar : PubMed/NCBI
21	Dong JT and Chen C: Essential role of KLF5 transcription factor in cell proliferation and differentiation and its implications for human diseases. Cell Mol Life Sci. 66:2691–2706. 2009. View Article : Google Scholar : PubMed/NCBI
22	Agardh E, Lundstig A, Perfilyev A, Volkov P, Freiburghaus T, Lindholm E, Rönn T, Agardh CD and Ling C: Genome-wide analysis of DNA methylation in subjects with type 1 diabetes identifies epigenetic modifications associated with proliferative diabetic retinopathy. BMC Med. 13:1822015. View Article : Google Scholar : PubMed/NCBI
23	Kakimoto T, Okada K, Fujitaka K, Nishio M, Kato T, Fukunari A and Utsumi H: Quantitative analysis of markers of podocyte injury in the rat puromycin aminonucleoside nephropathy model. Exp Toxicol Pathol. 67:171–177. 2015. View Article : Google Scholar : PubMed/NCBI
24	Trachtman H, Del Pizzo R, Futterweit S, Levine D, Rao PS, Valderrama E and Sturman JA: Taurine attenuates renal disease in chronic puromycin aminonucleoside nephropathy. Am J Physiol. 262:F117–F123. 1992.PubMed/NCBI
25	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
26	Baĭramov RB and Abdullaeva RT: The impact of early gastric cancer diagnosis on indices of survival in patients after radical surgical intervention. Klin Khir. 1–21. 2013.
27	Krolewski AS, Skupien J, Rossing P and Warram JH: Fast renal decline to end-stage renal disease: An unrecognized feature of nephropathy in diabetes. Kidney Int. 91:1300–1311. 2017. View Article : Google Scholar : PubMed/NCBI
28	Kowluru RA and Mishra M: Oxidative stress, mitochondrial damage and diabetic retinopathy. Biochim Biophys Acta. 1852:2474–2483. 2015. View Article : Google Scholar : PubMed/NCBI
29	Aoki Y, Yazaki K, Shirotori K, Yanagisawa Y, Oguchi H, Kiyosawa K and Furuta S: Stiffening of connective tissue in elderly diabetic patients: Relevance to diabetic nephropathy and oxidative stress. Diabetologia. 36:79–83. 1993. View Article : Google Scholar : PubMed/NCBI
30	Yasuno K, Kamiie J and Shirota K: Analysis of ultrastructural glomerular basement membrane lesions and podocytes associated with proteinuria and sclerosis in Osborne-Mendel rats with progressive glomerulonephropathy. J Vet Sci. 14:223–226. 2013. View Article : Google Scholar : PubMed/NCBI
31	Yu H, Kistler A, Faridi MH, Meyer JO, Tryniszewska B, Mehta D, Yue L, Dryer S and Reiser J: Synaptopodin limits TRPC6 podocyte surface expression and attenuates proteinuria. J Am Soc Nephrol. 27:3308–3319. 2016. View Article : Google Scholar : PubMed/NCBI
32	Kriz W and Lemley KV: Potential relevance of shear stress for slit diaphragm and podocyte function. Kidney Int. 91:1283–1286. 2017. View Article : Google Scholar : PubMed/NCBI
33	Cara-Fuentes G, Clapp WL, Johnson RJ and Garin EH: Pathogenesis of proteinuria in idiopathic minimal change disease: Molecular mechanisms. Pediatr Nephrol. 31:2179–2189. 2016. View Article : Google Scholar : PubMed/NCBI
34	Li X, Zhang X, Li X, Ding F and Ding J: The role of survivin in podocyte injury induced by puromycin aminonucleoside. Int J Mol Sci. 15:6657–6673. 2014. View Article : Google Scholar : PubMed/NCBI
35	Yu SY and Qi R: Role of bad in podocyte apoptosis induced by puromycin aminonucleoside. Transplant Proc. 45:569–573. 2013. View Article : Google Scholar : PubMed/NCBI
36	Zennaro C, Rastaldi MP, Pascolo L, Stebel M, Trevisan E, Artero M, Tiribelli C, Di Maso V and Carraro M: Podocyte expression of membrane transporters involved in puromycin aminonucleoside-mediated injury. PLoS One. 8:e661592013. View Article : Google Scholar : PubMed/NCBI
37	Marrero-Rodríguez D, Taniguchi-Ponciano K, Jimenez-Vega F, Romero-Morelos P, Mendoza-Rodríguez M, Mantilla A, Rodriguez-Esquivel M, Hernandez D, Hernandez A, Gomez-Gutierrez G, et al: Krüppel-like factor 5 as potential molecular marker in cervical cancer and the KLF family profile expression. Tumour Biol. 35:11399–11407. 2014. View Article : Google Scholar : PubMed/NCBI
38	Sousa MI, Rodrigues AS, Pereira S, Perestrelo T, Correia M and Ramalho-Santos J: Mitochondrial mechanisms of metabolic reprogramming in proliferating cells. Curr Med Chem. 22:2493–2504. 2015. View Article : Google Scholar : PubMed/NCBI
39	Ci X, Xing C, Zhang B, Zhang Z, Ni JJ, Zhou W and Dong JT: KLF5 inhibits angiogenesis in PTEN-deficient prostate cancer by attenuating AKT activation and subsequent HIF1α accumulation. Mol Cancer. 14:912015. View Article : Google Scholar : PubMed/NCBI
40	Amirak E, Zakkar M, Evans PC and Kemp PR: Perfusion of veins at arterial pressure increases the expression of KLF5 and cell cycle genes in smooth muscle cells. Biochem Biophys Res Commun. 391:818–823. 2010. View Article : Google Scholar : PubMed/NCBI
41	Xiao H, Shi W, Liu S, Wang W, Zhang B, Zhang Y, Xu L, Liang X and Liang Y: 1,25-Dihydroxyvitamin D(3) prevents puromycin aminonucleoside-induced apoptosis of glomerular podocytes by activating the phosphatidylinositol 3-kinase/Akt-signaling pathway. Am J Nephrol. 30:34–43. 2009. View Article : Google Scholar : PubMed/NCBI
42	Qin WW, Zhang R, Chen RA, Li GH, Ji YR, Liu L and Wang T: MicroRNA-145 induces cell cycle arrest in G1 phase by directly targeting KLF5 in colon cancer. Int J Clin Exp Pathol. 9:5197–5209. 2016.
43	Gaestel M: MAPK-activated protein kinases (MKs): Novel insights and challenges. Front Cell Dev Biol. 3:882016. View Article : Google Scholar : PubMed/NCBI
44	Hettenhausen C, Schuman MC and Wu J: MAPK signaling: A key element in plant defense response to insects. Insect Sci. 22:157–164. 2015. View Article : Google Scholar : PubMed/NCBI
45	O'Callaghan C, Fanning LJ and Barry OP: p38δ MAPK: Emerging roles of a neglected isoform. Int J Cell Biol. 2014:2726892014.PubMed/NCBI
46	Zhang Q, Wang J, Duan MT, Han SP, Zeng XY and Wang JY: NF-κB, ERK, p38 MAPK and JNK contribute to the initiation and/or maintenance of mechanical allodynia induced by tumor necrosis factor-alpha in the red nucleus. Brain Res Bull. 99:132–139. 2013. View Article : Google Scholar : PubMed/NCBI
47	Cuadrado A and Nebreda AR: Mechanisms and functions of p38 MAPK signalling. Biochem J. 429:403–417. 2010. View Article : Google Scholar : PubMed/NCBI
48	Liu R, Zheng HQ, Zhou Z, Dong JT and Chen C: KLF5 promotes breast cell survival partially through fibroblast growth factor-binding protein 1-pERK-mediated dual specificity MKP-1 protein phosphorylation and stabilization. J Biol Chem. 284:16791–16798. 2009. View Article : Google Scholar : PubMed/NCBI